...
首页> 外文期刊>Life sciences >Micturition dysfunction in four-month old ovariectomized rats: Effects of testosterone replacement
【24h】

Micturition dysfunction in four-month old ovariectomized rats: Effects of testosterone replacement

机译:四个月大型卵巢切除大鼠的测量术功能障碍:睾酮替代的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Aims Androgen deficiency has been implicated in urological complications of postmenopausal women. This study examined the effects of testosterone replacements on the lower urinary tract dysfunction in 4-month old ovariectomized (OVX) rats. Main methods Sprague-Dawley female rats were OVX bilaterally. Three months later, rats received single intramuscular injections of testosterone undecanoate. Cystometric study, and bladder and urethra smooth muscle reactivities were evaluated. Key findings Ovariectomy reduced by 65% (p 0.05) the serum testosterone levels. Testosterone replacement at 5 mg/kg restored serum hormone levels to baseline, whereas 10 mg/kg produced 14-fold higher testosterone levels. OVX rats exhibited significant increases of body weight, perigonadal fat and blood pressure, and reduced uterus weight, but none of these parameters were changed by testosterone replacements. OVX rats exhibited micturition dysfunction characterized by increases of basal pressure, threshold pressure, voiding frequency and post-voiding pressure. In addition, the bladder contractions induced by electrical-field stimulation (EFS) and carbachol were significantly reduced, whereas angiotensin II-induced urethral contractions were significantly increased in OVX rats. Testosterone replacement at 10 mg/kg (but not at 5 mg/kg) dose fully normalized the in vivo micturition dysfunction, as well as the in vitro bladder and urethral alterations. Testosterone (10 mg/kg) also significantly potentiated the bladder relaxations induced by the β 3 -adrenoceptor agonist mirabegron. The protective effects of testosterone were not modified by concomitant treatment with the aromatase inhibitor letrozole (2.5 mg/kg, 4 weeks). Significance The improvement of micturition dysfunction by testosterone replacement suggests that androgen therapy might be of therapeutic benefit for urological complications associated with post-menopause. Highlights ? Four-month old OVX rats proving a suitable experimental model for exploring the lower urinary function after menopause ? Testosterone normalizes micturition dysfunction in 4-month old OVX rats ? Would be clinically relevant to examine testosterone administration in postmenopausal women with urological disorders; or testosterone administration should be examined in postmenopausal women with urological disorders.
机译:摘要目的雄激素缺乏症涉及绝经后妇女的泌尿外科并发症。本研究检测了睾酮替代对4个月大鼠卵巢(OVX)大鼠的尿道功能障碍的影响。主要方法Sprague-Dawley雌性大鼠是双边的OVX。三个月后,大鼠接受了单肌肉内注射的睾酮未成熟。评估囊曲线研究,并评估膀胱和尿道平滑肌反应性。主要发现卵巢切除术减少65%(P <0.05)血清睾酮水平。睾酮替代5mg / kg恢复为基线的血清激素水平,而10 mg / kg产生14倍的睾酮水平。 OVX大鼠表现出体重,Pergonadal脂肪和血压的显着增加,并且减少了子宫重量,但这些参数没有睾酮替代改变。 OVX大鼠表现出逐步功能障碍,其特征在于基础压力,阈值压力,空隙频率和空隙后压力增加。此外,由电场刺激(EFS)和鱼肠诱导的膀胱收缩显着降低,而血管紧张素II诱导的尿道rall术在OVX大鼠中显着增加。睾酮在10mg / kg(但不是5mg / kg)的替代剂量完全标准化了体内尿素功能障碍,以及体外膀胱和尿道改变。睾酮(10mg / kg)也显着提高了β3 - 肾上腺素受体激动剂Mirabegron诱导的膀胱松弛。通过伴随芳香酶抑制剂Letrozole(2.5mg / kg,4周)的治疗没有改性睾酮的保护作用。意义对睾酮替代物的尿素功能障碍的改善表明,雄激素治疗可能具有治疗益处,用于与绝经后相关的泌尿外因并发症。强调 ?为期四个月的OVX大鼠,证明了更适合探索更年期后尿液功能的合适实验模型?睾酮在4个月大ovx大鼠中归一成位于误诊功能障碍?临床上与患有泌尿外代妇女的绝经后患者睾酮给药;或睾酮给药应在绝经后患有泌尿病患者中检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号